Effect of Beta-Blocker Therapy on Survival in Patients With Severe Aortic Regurgitation
Authors:
- Padmini VaradarajanPVPadmini Varadarajan
- Rami TurkRTRami Turk
- Ashvin KamathAKAshvin Kamath
- Sumit KhandharSKSumit Khandhar
- Ramdas G. PaiRPRamdas G. Pai
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Benefits of long-term β-blockade in experimental chronic aortic regurgitationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levelsInternational Journal of Cardiology, 2005
- Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitorsEuropean Heart Journal, 2005
- Effects of Different Degrees of Sympathetic Antagonism on Cytokine Network in Patients With Ischemic Dilated CardiomyopathyJournal of Cardiac Failure, 2005
- TISSUE- AND DOSE-DEPENDENT ALTERATION OF STRESS-INDUCIBLE PROTEINS BY β2-ADRENOCEPTOR AGONIST, SALBUTAMOL, IN RATSThe Journal of Toxicological Sciences, 2005
- Effectiveness of β-Blockade in Experimental Chronic Aortic RegurgitationCirculation, 2004
- Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiographyJournal of the American Society of Echocardiography, 2003
- Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cellsCardiovascular Research, 2001
- Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathyJACC, 2001
- Aortic regurgitation. A lesion with similarities to both aortic stenosis and mitral regurgitation.Circulation, 1990